SUO 2016: Competing trade-offs for kidney cancer surveillance - Session Highlights
San Antonio, Texas USA (UroToday.com) Tracey Krupski, University of Virginia, discussed surveillance for kidney cancer. The current AUA guidelines apply risk stratification to renal masses with varying follow-up.
These recommendations are not based on level one evidence. SEER-Medicare data among patients who underwent partial nephrectomy, approximately 15% of patients underwent guideline recommended surveillance following treatment with 33% having no abdominal imaging. Up to 40$ had more imaging than guideline recommendations. Using Monte Carlo modeling further refinement of imaging according to tumor size, costs and radiation exposure, however, there are inherent limitations of this type of modeling.
Presented By: Tracey Krupski, University of Virginia
Written By: Stephen B. Williams, MD and Ashish M. Kamat
17th Annual Meeting of the Society of Urologic Oncology - November 30 -December 2, 2016 – San Antonio, Texas USA